Service Temporarily Unavailable

Our team are currently in the process of updating the security we have installed on the site. Please be patient as we hope to have our service running again very soon.

Calendar of Events Latest Events

Calendar of Events


EvaluatePharma®’s Calendar of Events is the first fully comprehensive online service to track events impacting shareholder value, including:

  • PDUFA data
  • Filings and approvals
  • Clinical trial initiation and results
  • Patent expiries and generic launches

Contact us to find out more

Read more about our Calendar of Events

About EvaluatePharma®

Our expertise is trusted and relied upon by the top global pharma and biotech companies, the investment community and leading consultancies - Request a Free Trial to find out why.


Press Release


How to access FREE content

  • Search the content using the search box at the top of every page
  • Browse content by Company, Product, Generic Name, Therapeutic Category or Indication using "Browse By" link from the navigation bar
  • Create Peer Groups to compare Companies using "Peer Groups" link from the navigation bar

Download our brochure to discover Analysis & Insight Exclusive to EvaluatePharma

From Business Development & Licensing to Investment Banking see our range of Solutions.

Request a Free Trial to access our full service

Welcome to EvaluatePharma®

The premier source for pharma and biotech analysis delivering exclusive, trusted commercial insight into industry performance for over 10 years.

Download our NEW World Preview 2016 (June 2011)


EP Clinical Trials

Welcome to a confident new world of clinical trial intelligence that’s exceptionally faster than doing it yourself. Introducing our new affordable one-stop service.

Tired of mining clinical trial data from public sites? We do the work so you don’t have to.

See how our unrivalled access to cross-linked trial records of ClinicalTrials.gov and EudraCT can help you - Request a Demo


EP Vantage proud to be Commentator of the Year at European Mediscience Awards 2011

European Mediscience Commentator of the Year 2011

EP Vantage is proud to have won the European Mediscience Commentator of the Year award for 2011.


Looking for Partnering Opportunities?

Looking for Partnering Opportunities?

EvaluatePharma® now offers you access to Partnering Opportunities featuring the latest assets available for Partnering.

Do you have products to out-license? Register to submit your products to EvaluatePharma®’s Partnering Opportunities to reach our global audience of business development and licensing professionals at the world’s top pharma companies.

As a registered User, you can also view Partnering Opportunities, by Company or Product, from the Deals tab.

Find Out More

View the Partnering Opportunity Summary Page.


You are currently a Guest User – giving you FREE access to a selection of historical analyses and insights from EvaluatePharma®.

Options:

  1. Access FREE content as a Guest User
  2. Register Now for FREE to access more content including 2010 Product Sales and Rankings
  3. Request a Free Trial for full access to EvaluatePharma or Subscribe Now

Find out why so many corporations rely on Our Products, including EvaluatePharma Alpha, to shape their view of the future performance of their industry.


The Queen's Awards for Enterprise: International Trade 2009

WINNER OF QUEEN'S AWARD
FOR ENTERPRISE: INTERNATIONAL
TRADE 2009

Read more


Press Release:  R&D productivity measures consistently under-scored and under-valued


Follow evaluatepharma on Twitter

Company & Product Rankings Commercial rankings - leading products and companies
MS: Top 5 Products 2012
 
     Note:  Worldwide market share for Multiple Sclerosis products in 2012, based on company
     consolidated sales.
     Source: EvaluatePharma® consensus forecasts
Deals Licensing and M&A
Deal Announcement DateDeal Announcement Date Target Company or Business Unit Deal Value ($m) Acquiring Company M&A Deal Status
08/12/2011 Guangdong BeiKang Pharmaceutical Company - AstraZeneca Open
21/11/2011 Pharmasset 11,000 Gilead Sciences Open
20/11/2011 iNova Pharmaceuticals 709 Valeant Pharmaceuticals International Open
18/11/2011 Graceway Pharmaceuticals 455 Medicis Pharmaceutical Closed
08/11/2011 Artisan Pharma - Asahi Kasei Closed
08/11/2011 Oceana Therapeutics 300 Salix Pharmaceuticals Closed
07/11/2011 WellSpring Pharmaceutical - Consortium of Investors Closed
01/11/2011 SurModics (Pharmaceutical assets) 30 Evonik Industries Closed
27/10/2011 DuoCort 165 ViroPharma Closed
27/10/2011 Novozymes Biopharma Sweden 28 Repligen Closed